Advertisement

Cutaneous Manifestations of HIV in Children

  • Antoinette Chateau
  • Anisa MosamEmail author
Chapter
  • 18 Downloads

Abstract

Skin manifestations are common in HIV infected patients with a prevalence rate ranging from 36% to 52% in children and 41% to 94% in adults. At least 30% present with skin conditions as a manifestation of their underlying HIV and 90% manifest with skin conditions during the course of HIV. In addition, therapy with antiretroviral therapy is responsible for drug reactions and immune reconstitution syndrome which most commonly presents with skin lesions. Common dermatoses are more severe and recalcitrant to therapy in HIV infected patients; however, there may be skin conditions that are specific and occur only in the context of HIV infection. Thus, early recognition of skin lesions can prompt investigation and early management of HIV infection as well as recognition of failure and resistance to antiretroviral therapy.

Keywords

HIV and skin Infections Inflammatory Immune reconstitution Failure Drug reactions Early recognition 

References

  1. 1.
    Mankahla A, Mosam A. Common skin conditions in children with HIV/AIDS. Am J Clin Dermatol. 2012;13(3):153–66.CrossRefGoogle Scholar
  2. 2.
    Rodgers S, Leslie KS. Skin infections in HIV-infected individuals in the era of HAART. Curr Opin Infect Dis. 2011;24(2):124–9.CrossRefGoogle Scholar
  3. 3.
    Paller A, Mancini A. Hurwitz’s pediatric dermatology. 4th ed. London: Elsevier; 2011. p. 632.Google Scholar
  4. 4.
    Armenian SH, Han JY, Dunaway TM, Church JA. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Pediatr Infect Dis J. 2006;25(4):368–70.CrossRefGoogle Scholar
  5. 5.
    Hogan MT. Cutaneous infections associated with HIV/AIDS. Dermatol Clin. 2006;24(4):473–95.CrossRefGoogle Scholar
  6. 6.
    Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet. 1996;348(9028):659–63.CrossRefGoogle Scholar
  7. 7.
    Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol. 1992;27(4):583–8.CrossRefGoogle Scholar
  8. 8.
    Vicente A, Pau-Charles I, González-Enseñat MA, Muñoz-Almagro C, Cañadas MP, Noguera-Julian A, et al. High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2013;68(2):343–5.CrossRefGoogle Scholar
  9. 9.
    Motswaledi MH, Visser W. The spectrum of HIV-associated infective and inflammatory dermatoses in pigmented skin. Dermatol Clin. 2014;32(2):211–25.CrossRefGoogle Scholar
  10. 10.
    Prendergast AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, Kekitiinwa A, Thomason MJ, et al. Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis. AIDS. 2016;30(18):2823–9.CrossRefGoogle Scholar
  11. 11.
    Srinivasan A, Seifried S, Zhu L, Bitar W, Srivastava DK, Shenep JL, et al. Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retrovir. 2009;25(12):1219–24.CrossRefGoogle Scholar
  12. 12.
    Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J. 2013;32(Suppl 2):i–KK4.CrossRefGoogle Scholar
  13. 13.
    Admani S, Jinna S, Friedlander SF, Sloan B. Cutaneous infectious diseases: Kids are not just little people. Clin Dermatol. 2015;33(6):657–71.CrossRefGoogle Scholar
  14. 14.
    Jordaan HF. Common skin and mucosal disorders in HIV/AIDS. South Afr Family Pract. 2008;50(6):14–23.CrossRefGoogle Scholar
  15. 15.
    dos Santos Pinheiro R, Franca TT, Ribeiro CM, Leao JC, de Souza IP, Castro GF. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. J Oral Pathol Med. 2009;38(8):613–22.CrossRefGoogle Scholar
  16. 16.
    Pirofski L-A. Fungal infections in children with human immunodeficiency virus infection. Seminars Pediatr Infect Dis. 2001;12(4):288–95.CrossRefGoogle Scholar
  17. 17.
    Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343–51.CrossRefGoogle Scholar
  18. 18.
    Resneck JS Jr, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004;292(21):2614–21.CrossRefGoogle Scholar
  19. 19.
    Castelnuovo B, Byakwaga H, Menten J, Schaefer P, Kamya M, Colebunders R. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? AIDS. 2008;22(2):269–73.CrossRefGoogle Scholar
  20. 20.
    Samanta M, Kundu C, Sarkar M, Bhattacharyya S, Chatterjee S. Papular pruritic eruptions: a marker of progressive HIV disease in children: Experience from eastern India. Ind J Sex Trans Dis AIDS. 2009;30(2):79–83.CrossRefGoogle Scholar
  21. 21.
    Hill TA, Cohen B. Scabies in babies. Pediatr Dermatol. 2017;34(6):690–4.CrossRefGoogle Scholar
  22. 22.
    Murdoch DM, Venter WDF, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007;4:9.CrossRefGoogle Scholar
  23. 23.
    Smith K, Kuhn L, Coovadia A, Meyers T, Hu CC, Reitz C, et al. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009;23(9):1097–107.CrossRefGoogle Scholar
  24. 24.
    Gkentzi D, Tebruegge M, Tudor-Williams G, Walters S, Lyall H, Sharland M, et al. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy. Pediatr Infect Dis J. 2014;33(9):953–8.CrossRefGoogle Scholar
  25. 25.
    Orikiiriza J, Bakeera-Kitaka S, Musiime V, Mworozi EA, Mugyenyi P, Boulware DR. The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS. 2010;24(13):2009–17.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of DermatologyNelson R Mandela School of Medicine, UKZNDurbanSouth Africa

Personalised recommendations